Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H4N2O |
| Molecular Weight | 96.0874 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1NC=NC=C1
InChI
InChIKey=DNCYBUMDUBHIJZ-UHFFFAOYSA-N
InChI=1S/C4H4N2O/c7-4-1-2-5-3-6-4/h1-3H,(H,5,6,7)
| Molecular Formula | C4H4N2O |
| Molecular Weight | 96.0874 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. | 2010-12-16 |
|
| Tautomerism in 4-hydroxypyrimidine, S-methyl-2-thiouracil, and 2-thiouracil. | 2010-12-09 |
|
| A short synthesis of the triazolopyrimidine antibiotic essramycin. | 2010-11-29 |
|
| 2-Isopropyl-6-methyl-pyrimidin-4(3H)-one. | 2010-08-28 |
|
| 3-Phenyl-2-(pyrrolidin-1-yl)-5,6-dihydro-8H-thio-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one. | 2010-08-25 |
|
| Titanium(IV) isopropoxide mediated synthesis of pyrimidin-4-ones. | 2010-05-21 |
|
| Comparison of the non-radiative decay mechanisms of 4-pyrimidinone and uracil: an ab initio study. | 2010-05-21 |
|
| Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents. | 2010-05-15 |
|
| Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. | 2010-04-01 |
|
| A eukaryotic-acquired gene by a biotrophic phytopathogen allows prolonged survival on the host by counteracting the shut-down of plant photosynthesis. | 2010-01-28 |
|
| Role of the carbonyl group of the (6-4) photoproduct in the (6-4) photolyase reaction. | 2009-10-06 |
|
| Formation of uracil from the ultraviolet photo-irradiation of pyrimidine in pure H2O ices. | 2009-09 |
|
| 6-Amino-2,5-bis-(pivaloylamino)pyrimidin-4(3H)-one dihydrate. | 2009-06-06 |
|
| An iron(II) dependent formamide hydrolase catalyzes the second step in the archaeal biosynthetic pathway to riboflavin and 7,8-didemethyl-8-hydroxy-5-deazariboflavin. | 2009-05-19 |
|
| Parallel solid-phase synthesis and high-throughput 1H NMR evaluation of a 96-member 1,2,4-trisubstituted-pyrimidin-6-one-5-carboxylic acid library. | 2009-03-20 |
|
| Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. | 2009-03-05 |
|
| Inhibition of iNOS and COX-2 in human whole blood ex vivo and monocyte-macrophage J774 cells by a new group of aminothiopyrimidone derivatives. | 2009-03-01 |
|
| Pyrimidone derivative inhibits simian immunodeficiency virus-induced apoptosis of CEM x174 cells. | 2009-02 |
|
| Spectroscopic analysis of the pyrimidine(6-4)pyrimidone photoproduct: insights into the (6-4) photolyase reaction. | 2009-01-07 |
|
| Recognition and reaction mechanisms of the (6-4) photolyase as determined by using a (6-4) photoproduct analog. | 2009 |
|
| Synthesis, structure and spectral investigation of hydrogen bonded helical chain in mixed ligand Cu(II) pyrimidone complex. | 2008-11-15 |
|
| Design, synthesis, and biological evaluation of potent c-Met inhibitors. | 2008-09-25 |
|
| Bis[μ-3-(2-hydroxy-ethyl)-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-olato-κN,O:O]bis[aquachloridocopper(II)]. | 2008-09-13 |
|
| 3D-QSAR CoMFA of a series of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors. | 2008-08 |
|
| The mechanism of ureido-pyrimidinone:2,7-diamido-naphthyridine complexation and the presence of kinetically controlled pathways in multicomponent hydrogen-bonded systems. | 2008-04-23 |
|
| The first metal complexes of 4,6-diamino-1-hydro-5-hydroxy-pyrimidine-2-thione: preparation, physical and spectroscopic studies, and preliminary antimicrobial properties. | 2008 |
|
| Formamide as the main building block in the origin of nucleic acids. | 2007-08-16 |
|
| Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides. | 2007-07-26 |
|
| Probing the solvent-induced tautomerism of a redox-active ureidopyrimidinone. | 2007-06-14 |
|
| Systematic effect of benzo-annelation on oxo-hydroxy tautomerism of heterocyclic compounds. Experimental matrix-isolation and theoretical study. | 2007-06-14 |
|
| Gas-phase tautomeric equilibrium of 4-hydroxypyrimidine with its ketonic forms: a free jet millimeterwave spectroscopy study. | 2007-05-16 |
|
| How resonance assists hydrogen bonding interactions: an energy decomposition analysis. | 2007-01-15 |
|
| Spectroscopic studies on a novel intramolecular hydrogen bond within the (6-4) photoproduct. | 2007 |
|
| Dimerization and double proton transfer-induced tautomerism of 4(3H)-pyrimidinone in solution studied by IR spectroscopy and quantum chemical calculations. | 2006-12-28 |
|
| UV-induced generation of rare tautomers of allopurinol and 9-methylhypoxanthine -- a matrix isolation FTIR study. | 2006-07-20 |
|
| Analytical and semipreparative high performance liquid chromatography separation of stereoisomers of novel 3,4-dihydropyrimidin-4(3H)-one derivatives on the immobilised amylose-based Chiralpak IA chiral stationary phase. | 2006-07 |
|
| H2, N2, CO, and CO2 sorption properties of a series of robust sodalite-type microporous coordination polymers. | 2006-03-20 |
|
| Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin. | 2005-09 |
|
| Nucleotide excision repair activity varies among murine spermatogenic cell types. | 2005-07 |
|
| Ureidopyrimidinones incorporating a functionalizable p-aminophenyl electron-donating group at C-6. | 2005-04-01 |
|
| A theoretical study on the structure-activity relationships of metabolites of folates as antioxidants and its implications for rational design of antioxidants. | 2005-02-15 |
|
| Phenoxydifluoromethyl substituted nitrogen heterocycles. Synthesis and heterocyclization reactions of ethyl 4,4-difluoro- 4-phenoxyacetoacetate. | 2004-02-28 |
|
| Coordination frameworks containing the pyrimidin-4-olate ligand. Synthesis, thermal, magnetic, and ab initio XRPD structural characterization of nickel and zinc derivatives. | 2004-01-26 |
|
| Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin. | 2003-04 |
|
| The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. | 2003-03-24 |
|
| Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis. | 2003-01-02 |
|
| Ab initio study of the (5R)- and (5S)-TT pyrimidine h5(6-4) pyrimidone photoproducts. Implications on the design of new biologically relevant analogues. | 2002-12-27 |
|
| PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes. | 2002-09 |
|
| Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii. | 1995-11-09 |
|
| Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii. | 1994-08-17 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:18:47 GMT 2025
by
admin
on
Mon Mar 31 19:18:47 GMT 2025
|
| Record UNII |
K43V90OY4L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
224-932-4
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY | |||
|
157911
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY | |||
|
K43V90OY4L
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY | |||
|
20695
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY | |||
|
4562-27-0
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY | |||
|
DTXSID5063524
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY | |||
|
1575
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY | |||
|
51953-18-5
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
ALTERNATIVE | |||
|
Pyrimidone
Created by
admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
|
PRIMARY |